BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Liver
,
Metabolism of nitric oxide
,
Clofibrate
,
rs2300478
,
SNCA
,
Apoptosis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
way 123, 398
Summary
General Info
Curated Studies
Most Correlated Studies
There were no matches for way 123, 398
Explore Curated Studies Results
Literature
Most Relevant Literature
3H]dofetilide binding to HERG transfected membranes: a potential high throughput preclinical screen.
3H]dofetilide binding in SHSY5Y and HEK293 cells expressing a HERG-like K+ channel?
HERG potassium channels are constitutively expressed in primary human acute myeloid leukemias and re…
Separation of M-like current and ERG current in NG108-15 cells.
HERG potassium channels are more frequently expressed in human endometrial cancer as compared to non…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT
Smoking Cessation Versus Long-term Nicotine Replacement Among High-risk Smokers
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of …
Pembrolizumab and Dasatinib, Imatinib Mesylate, or Nilotinib in Treating Patients With Chronic Myelo…
A Study Testing the Effect of Immunotherapy (Ipilimumab and Nivolumab) in Patients With Recurrent Gl…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ